Sickle Cell Trait Clinical Trials
2 recruiting trials for Sickle Cell Trait. Eligibility criteria explained in plain English.
TrialFinderData lists 2 Sickle Cell Trait clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by UConn Health (1), National Alliance for Sickle Cell Centers (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is Healthy volunteers without SCT (other, 1 trial), followed by Healthy volunteers with SCT, Biologic Specimen Collection.
Track Sickle Cell Trait trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
Bone Loss, Physical Function and Frailty in Older Women With Sickle Cell Trait Sickle Cell Trait
This is a cross-sectional, clinical research study comparing postmenopausal women of African Descent (AD) with different hemoglobin genotypes: normal and sickle cell trait (SCT)....
Achieving Understanding of the Natural History of Sickle Cell Trait (AUNT)
The main purpose of this study is to create a longitudinal cohort of those with Sickle Cell Trait (SCT) to better understand the hematologic phenotype for those that carry HbS,...
Explore Other Conditions
Frequently Asked Questions
There are currently 2 clinical trials for Sickle Cell Trait, with 2 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Sickle Cell Trait, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Sickle Cell Trait, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.